Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D
The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLRA1 | P23415 | 1/20 | 0.71 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.71 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.71 |
| ▸ | FFAR3 | O14843 | 3/20 | 0.50 |
| ▸ | LCK | P06239 | 1/20 | 0.50 |
| ▸ | FYN | P06241 | 1/20 | 0.50 |
| ▸ | GABRR1 | P24046 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 6/20 | 0.40 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.39 |
| ▸ | KDM6B | O15054 | 1/20 | 0.39 |
| ▸ | KDM5C | P41229 | 1/20 | 0.39 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.39 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 3/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycine SCHEMBL11291516 | 0.96 | GLRA1 (0.77) | GLRA1SLC6A9OR51E2FFAR3LCK | |
| Glycine SCHEMBL907052 | 0.96 | GLRA1 (0.77) | GLRA1SLC6A9OR51E2FFAR3LCK | |
| Glycine SCHEMBL318020 | 0.96 | — | — | |
| Glycine SCHEMBL7918812 | 0.96 | GLRA1 (0.77) | GLRA1SLC6A9OR51E2FFAR3LCK | |
| Glycine SCHEMBL29244710 | 0.96 | GLRA1 (0.77) | GLRA1SLC6A9OR51E2FFAR3LCK | |
| Glycine SCHEMBL11421944 | 0.93 | GLRA1 (0.71) | GLRA1SLC6A9OR51E2FFAR3LCK | |
| Glycine SCHEMBL3343294 | 0.93 | GLRA1 (0.71) | GLRA1SLC6A9OR51E2FFAR3LCK | |
| Glycine SCHEMBL1285648 | 0.93 | GLRA1 (0.71) | GLRA1SLC6A9OR51E2FFAR3LCK | |
| Glycine SCHEMBL20854478 | 0.93 | GLRA1 (0.71) | GLRA1SLC6A9OR51E2FFAR3LCK | |
| Glycine SCHEMBL1321711 | 0.93 | GLRA1 (0.71) | GLRA1SLC6A9OR51E2FFAR3LCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007136727-A2 | IRON (II) AMINO ACID CHELATES WITH REDUCING AGENTS ATTACHED THERETO | ALBION INTERNATIONAL, INC. (US) | 2007-11-29 | — | — | WO | disclosed |
| US-20070270591-A1 | Iron (II) amino acid chelates with reducing agents attached thereto | ALBION INTERNATIONAL, INC. | 2007-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070270591-A1 | Iron (II) amino acid chelates with reducing agents attached thereto | SLC40A1, TFRC, PPOX | GLRA1 741/4885SLC6A9 657/4885OR51E2 1257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.